Study Evaluating The Effect Of Ramipril On Urinary Protein Excretion In Renal Transplant Patients Converted To Sirolimus
Status:
Completed
Trial end date:
2013-09-01
Target enrollment:
Participant gender:
Summary
The primary objective of the study is to determine the efficacy of ramipril in preventing a
urinary protein to creatinine ratio (U p/c) greater than 0.5 following conversion to
sirolimus from a calcineurin inhibitor (CNI) in maintenance kidney transplant patients.